Skip to main content
Top

International Journal of Hematology

Issue 6/2021

Content (13 Articles)

Lymphoma Review Article

Heterogeneity in the diagnosis of plasmablastic lymphoma, plasmablastic myeloma, and plasmablastic neoplasm: a scoping review

Hirotaka Mori, Masahiko Fukatsu, Hiroshi Ohkawara, Yuka Oka, Yuki Kataoka, Shunsuke Taito, Takayuki Ikezoe

Multiple Myeloma Original Article

Carfilzomib, dexamethasone, and daratumumab in Asian patients with relapsed or refractory multiple myeloma: post hoc subgroup analysis of the phase 3 CANDOR trial

Kenshi Suzuki, Chang-Ki Min, Kihyun Kim, Je-Jung Lee, Hirohiko Shibayama, Po-Shen Ko, Shang-Yi Huang, Sin-Syue Li, Bifeng Ding, Monica Khurana, Shinsuke Iida

Pharmacokinetically guided, once-daily intravenous busulfan in combination with fludarabine for elderly AML/MDS patients as a conditioning regimen for allogeneic stem cell transplantation

Chikako Ohwada, Shingo Yamazaki, Katsuhiro Shono, Kensuke Kayamori, Yutaro Hino, Nagisa Oshima-Hasegawa, Tomoya Muto, Shokichi Tsukamoto, Shio Mitsukawa, Yusuke Takeda, Naoya Mimura, Masahiro Takeuchi, Tohru Iseki, Masahiro Onoda, Akira Yokota, Takaaki Suzuki, Itsuko Ishii, Chiaki Nakaseko, Emiko Sakaida

Chronic liver graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients during tapering or after stopping calcineurin inhibitors

Kazuki Yoshimura, Shun-ichi Kimura, Masakatsu Kawamura, Shunto Kawamura, Junko Takeshita, Nozomu Yoshino, Yukiko Misaki, Ayumi Gomyo, Shimpei Matsumi, Yu Akahoshi, Masaharu Tamaki, Machiko Kusuda, Kazuaki Kameda, Hidenori Wada, Koji Kawamura, Miki Sato, Kiriko Terasako-Saito, Aki Tanihara, Hideki Nakasone, Shinichi Kako, Yoshinobu Kanda

Vaccination Original Article

Assessment of cellular response to mitogens in long-term allogeneic hematopoietic stem cell transplantation survivors

Takahiko Sato, Miyo Goto, Marie Ohbiki, Tatsunori Goto, Takanobu Morishita, Aika Seto, Yukiyasu Ozawa, Koichi Miyamura

Granulocyte Transfusion Original Article

Granulocyte collection by polymorphonuclear cell-targeting apheresis with medium-molecular-weight hydroxyethyl starch

Tomoko Henzan, Takuji Yamauchi, Ikumi Yamanaka, Teppei Sakoda, Yuichiro Semba, Masayasu Hayashi, Yoshikane Kikushige, Hiroyuki Mishima, Masataka Ishimura, Yuhki Koga, Toshihiro Miyamoto, Shouichi Ohga, Koichi Akashi, Takahiro Maeda, Yuya Kunisaki

Characterization of localized macrophages in bronchiolitis obliterans after allogeneic hematopoietic cell transplantation

Taiga Kuroi, Nobuharu Fujii, Koichi Ichimura, Keisuke Seike, Akira Yamamoto, Yui Kambara, Seiichiro Sugimoto, Shinji Otani, Kyosuke Saeki, Hideaki Fujiwara, Hisakazu Nishiomori, Takahiro Oto, Yoshinobu Maeda

SARS-CoV-2 Original Article

Practical management of patients with hematological diseases during the COVID-19 pandemic in Japan

Masao Hagihara, Shin Ohara, Tomoyuki Uchida, Morihiro Inoue

Nosocomial Infection Original Article

Clinical characteristics and risk factors associated with nosocomial COVID-19 infection in patients with hematological disorders in Japan

Shin Ohara, Takayuki Fujii, Shiro Ide, Tomoyuki Uchida, Morihiro Inoue, Masao Hagaihara

Vemurafenib provides a rapid and robust clinical response in pediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease per ddPCR using cell-free circulating DNA

Dmitry Evseev, Irina Kalinina, Elena Raykina, Daria Osipova, Zalina Abashidze, Anna Ignatova, Anna Mitrofanova, Alexey Maschan, Galina Novichkova, Michael Maschan

Lymphoma Case Report

Refractory T-cell/histiocyte-rich large B-cell lymphoma in a patient with ataxia–telangiectasia caused by novel compound heterozygous variants in ATM

Daichi Sato, Kunihiko Moriya, Tomohiro Nakano, Chihiro Miyagawa, Saori Katayama, Hidetaka Niizuma, Yoji Sasahara, Shigeo Kure

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine